×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
ETR:MDG1

Medigene Stock Forecast, Price & News

€2.27
-0.05 (-2.16%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
€2.22
€2.39
50-Day Range
€2.32
€2.98
52-Week Range
€1.90
€4.59
Volume
23,248 shs
Average Volume
306,207 shs
Market Capitalization
$55.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Medigene MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive MDG1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medigene and its competitors with MarketBeat's FREE daily newsletter.

Medigene logo

About Medigene (ETR:MDG1) Stock

Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.

MDG1 Stock News Headlines

PTA-News: Medigene AG: Veränderung im Vorstand
MEDIGENE AG MEDIGENE K ORD SHS (0QGJ.IL)
PHIO: Intasyl Advantage vs. Gene Editing
MEDIGENE AG NA O.N. (MDG1.DU)
MediGene AG
Medigene H1 Net Loss Widens; Backs FY19 Outlook - Quick Facts
PHIO: Activation in the Tumor Microenvironment
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
58
Year Founded
N/A

Company Calendar

Today
7/04/2022
Next Earnings (Estimated)
8/03/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.46 million
Cash Flow
€0.80 per share
Book Value
€1.83 per share

Miscellaneous

Free Float
N/A
Market Cap
$55.76 million
Optionable
Not Optionable
Beta
N/A














Medigene Frequently Asked Questions

How has Medigene's stock price performed in 2022?

Medigene's stock was trading at €2.87 at the start of the year. Since then, MDG1 stock has decreased by 20.8% and is now trading at €2.27.
View the best growth stocks for 2022 here
.

When is Medigene's next earnings date?

Medigene is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Medigene
.

Who are Medigene's key executives?

Medigene's management team includes the following people:
  • Dr. Dolores J. Schendel, CEO, Chief Scientific Officer & Member of Exec. Management Board
  • Dr. Ernst-Ludwig Winnacker, Co-Founder & Chairman Scientific Advisory Board (Age 81)
  • Dr. Birger Kohlert, Chief Financial Officer
  • Dr. Anna Niedl, VP Investor Relations & Corp. Communications
  • Dr. Rene Goedkoop, Acting Chief Medical Officer

What other stocks do shareholders of Medigene own?

What is Medigene's stock symbol?

Medigene trades on the ETR under the ticker symbol "MDG1."

What is Medigene's stock price today?

One share of MDG1 stock can currently be purchased for approximately €2.27.

How much money does Medigene make?

Medigene (ETR:MDG1) has a market capitalization of $55.76 million and generates $10.46 million in revenue each year.

How many employees does Medigene have?

Medigene employs 58 workers across the globe.

How can I contact Medigene?

Medigene's mailing address is Lochhamer Strasse 11, PLANEGG, 82152, Germany. The official website for Medigene is www.medigene.de. The company can be reached via phone at +49-89-2000330.

This page (ETR:MDG1) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.